Matinas BioPharma Hldgs Q1 EPS $(0.30) Up From $(0.33) YoY

Benzinga Newsdesk www.benzinga.com Negative 52.0%

Neg 52% Neu 0% Pos 0%

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.30) per share. This is a 9.09 percent increase over losses of $(0.33) per share from the same period last year.